- 거버넌스 리스크 보관

IBK Industrial Bank Stock Holds As Profit Growth Slips: Key Risks

IBK Industrial Bank rated Hold: low valuation but weak net profit growth and unresolved governance or fraud-control risks keep upside capped and risk high.

2026년 09월 11일

English

Hanmi Pharmaceutical Stock Resilient Despite Profit Dip: Key Insight

Hanmi Pharmaceutical stock is discounted by governance and K-bio sentiment, but earnings remain resilient with net income up 6.8% YoY; analysts see Buy with 51% upside to the 624,615 won average target.